SONX (Sonendo) ROCE %: -145.17% (As of Dec. 2024)


SONX Sonendo Inc SONX
47 GF Score
Price $0.60
View Full Analysis

What is Sonendo ROCE %?

Sonendo SONX 47 ROCE % is -145.17% as of Dec. 2024. GuruFocus rates SONX with a GF Score™ of 47/100.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Sonendo's annualized ROCE % for the quarter that ended in Dec. 2024 was -145.17%.

Sonendo  (OTCPK:SONX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Sonendo ROCE % Related Terms

Sonendo ROCE % Historical Data

* Premium members only.

The historical data trend for Sonendo's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sonendo ROCE % Chart

Sonendo Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROCE %
Get a 7-Day Free Trial -74.03 -65.03 -48.61 -68.55 -103.64

Sonendo Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -63.91 -101.65 -80.57 -109.71 -145.17
SONX
47GF Score
Sonendo Inc SONX
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sonendo ROCE % Calculation

Sonendo's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=-28.069/( ( (78.16 - 35.321) + (31.265 - 19.939) )/ 2 )
=-28.069/( (42.839+11.326)/ 2 )
=-28.069/27.0825
=-103.64 %

Sonendo's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2024 )  (Q: Sep. 2024 )(Q: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2024 )  (Q: Sep. 2024 )(Q: Dec. 2024 )
=-22.024/( ( (38.131 - 19.115) + (31.265 - 19.939) )/ 2 )
=-22.024/( ( 19.016 + 11.326 )/ 2 )
=-22.024/15.171
=-145.17 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -145.17% mean?
Sonendo (SONX) has a ROCE % of -145.17% as of Dec. 2024.
Is Sonendo's ROCE % too high?
Sonendo's current ROCE % is -145.17%. Overall, Sonendo has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Sonendo's ROCE % compare to DHAI and AFIB?
Sonendo's ROCE % of -145.17% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sonendo's current ROCE % is -145.17%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sonendo stock overvalued right now?
Sonendo (SONX) has a current ROCE % of -145.17%. The current ROCE % is -145.17%. Sonendo's overall GF Score™ is 47/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Sonendo (SONX), the current ROCE % is -145.17% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sonendo Business Description

Address 26061 Merit Circle, Suite 102, Laguna Hills, CA, USA, 92653
Sonendo Inc is a commercial-stage medical technology company focused on saving teeth from tooth decay, the prevalent chronic disease globally. It has developed the GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company operates in two business segments, Product segment which derives key revenue, and Software. Product segment includes sales of the Company's GentleWave System console and related accessories and instruments. Software segment includes sales of the company's traditional software licenses for practice management software to enable an integrated digital office for endodontists.
47GF Score

Get the complete analysis for SONX

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.60
Price